UK preparing to meet 'inevitable' increased drug costs after US talks
By Alistair Smout LONDON (Reuters) -The British government is preparing to meet the "inevitable" inc...
28th October, 2025
By Alistair Smout LONDON (Reuters) -The British government is preparing to meet the "inevitable" inc...
28th October, 2025
(Reuters) -TerraPower, a nuclear innovation company founded by Bill Gates, has submitted a design fo...
28th October, 2025
RIYADH (Reuters) -Oracle CEO Mike Sicilia said on Tuesday that he is not concerned about an "AI bubb...
28th October, 2025
By Bhanvi Satija LONDON (Reuters) -Swiss drugmaker Novartis is exploring options to add more medicin...
28th October, 2025
ROME (Reuters) -Italian banks should use resources generated by the current favourable period to str...
28th October, 2025

By Marta Frackowiak and Anne Kauranen (Reuters) -Finnish engineering group Wartsila reported third-q...
28th October, 2025
(Reuters) -The head of the World Trade Organization (WTO) on Tuesday called for reforms of the 30-ye...
28th October, 2025
(Reuters) -French industrial gases group Air Liquide on Tuesday confirmed its 2026 margin outlook an...
28th October, 2025
By Leo Marchandon and Noemie Naudin (Reuters) -French IT consulting firm Capgemini raised its growth...
28th October, 2025
By Emma Rumney LONDON -British American Tobacco said it has paused a pilot plan to launch an unlicen...
28th October, 2025
(Reuters) -Britain's largest broadband provider BT Group is mulling the launch of a low-cost mobile...
28th October, 2025

(Reuters) -Russia has flown a second prototype of its MC-21 medium-haul passenger jet built with dom...
28th October, 2025